Infliximab
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Infliximab |
| DrugBank ID | DB00065 |
| KG Predictions | 40 |
| DL Predictions (≥0.7) | 21 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 40 knowledge graph predictions and 21 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| inflammatory bowel disease | KG |
| rheumatoid arthritis | KG |
| spondyloarthropathy, susceptibility to | KG |
| Crohn disease | KG |
| Crohn’s colitis | KG |
| psoriatic arthritis | KG |
| ankylosing spondylitis | KG |
| ulcerative colitis (disease) | KG |
| inflammatory bowel disease | KG |
| rheumatoid arthritis | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB00065
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.